Hans has been working in the pharmaceutical sector during his entire professional career. In the past 16 years, together with 400 great colleagues, they have transformed Tiofarma into a CDMO with broad capabilities and world-class knowledge and know-how of creams & ointments and nasal emergency medication.
At TIO, they have been involved in the repurposing of Colchicine for multiple new indications. Hans is passionate about finding a solution to make investments in patent-free molecules for new indications sustainable, hence valuable for society and worthwhile for investors.
